AGTC Awaits Data In Jan., EVFM Walks The Talk, Today's A Big Day For ALDX

Today's Daily Dose brings you news about Applied Genetic Technologies' near-term catalysts; the acquisition of Audentes by Astellas; Aldeyra's immediate catalyst; Evofem's AMPREVENCE study results and Lexicon Pharma's setback.

from RTT - Biotech https://ift.tt/2Rkrl2p
via IFTTT

Read More »

KOD Dazzles, GLMD On Watch, DRIO Turns Heads.

The following are some of today's top gainers in the healthcare sector.

from RTT - Biotech https://ift.tt/2OKJXXE
via IFTTT

Read More »

Futures Pointing To Initial Strength On Wall Street

The major U.S. index futures are currently pointing to a modestly higher opening on Monday following the pullback seen in the previous session.

from RTT - Market Analysis https://ift.tt/2P2z3LC
via IFTTT

Read More »

Mylan, Biocon Announce US Launch Of Trastuzumab Biosimilar Ogivri - Quick Facts

Pharmaceutical company Mylan N.V. (MYL) and India-based Biocon Ltd. announced Monday the U.S. launch of Ogivri (trastuzumab-dkst), a biosimilar to Herceptin (trastuzumab). The product is co-developed by Mylan and Biocon.

from RTT - Biotech https://ift.tt/34HeIlI
via IFTTT

Read More »

Sirona Biochem's Skin Lightening Agent Found To Be Safe At Higher Dose

Sirona Biochem Corp. (SBM.V) (SRBCF.OB) announced that its investigative skin lightening compound TFC-1067 has been successfully completed a toxicology test for an increased dose of 0.4%, in preparation for the new clinical study.

from RTT - Biotech https://ift.tt/2P24u8Q
via IFTTT

Read More »

Kadmon Holdings' (KDMN) Rocking, Will The Rally Continue?

Shares of Kadmon Holdings Inc. (KDMN) have gained an impressive 53% over the last 1 month.

from RTT - Biotech https://ift.tt/35XyYQl
via IFTTT

Read More »

Biotech Stocks Facing FDA Decision In December 2019

As we begin the final month of the year, it's time to take a look at the drug candidates lined up at the FDA altar awaiting the federal agency's decision.

from RTT - Biotech https://ift.tt/2syJD5r
via IFTTT

Read More »